Skip to content

Analysis of the influencing factors of rebound pain after single shot peripheral nerve block

Analysis of the influencing factors of rebound pain after single shot peripheral nerve block

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060203
Enrollment
Unknown
Registered
2022-05-22
Start date
2022-05-10
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperation pain

Interventions

Sponsors

The Third Affiliated Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years; 2. ASA I-III; 3. Subjects who underwent orthopedic surgery with open reduction and internal fixation of ankle fracture on a selective basis; 4. He voluntarily participated in and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Preoperative peripheral nerve injury or lesion; 2. Long-term oral painkillers due to chronic pain; 3. Serious composite trauma; 4. Pregnant women; 5. There was a history of steroid use within two weeks of the study; 6. There are contraindications of regional block; 7. Contraindications of dexamethasone (mental health disorder, cataract, glaucoma, bacteremia and systemic fungal infection, peptic ulcer disease, viral infection, such as herpes or the latest live vaccine); 8. Patients with diabetes who have a history of allergy to the study drug; 9. The wound is infected.

Design outcomes

Primary

MeasureTime frame
rebound pain;Duration of sensory and motor nerve block;Blood inflammation related indicators;endogenous opioid;Patient Recovery Quality Score;Postoperative opioid consumption;Numerical Rating Scale (NRS);

Secondary

MeasureTime frame
Patient satisfaction score;Postoperative nausea and vomiting;

Countries

hina

Contacts

Public ContactWang Qiujun

The Third Hospital of Hebei Medical University

wangqiujunsy@163.com+86 18533112929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026